Supplemental Digital Content Figure 1A A Academic/Research Program Extent of Lung Resection No. of SubjectEventCensored Median Survival (95% CI)60 mo Survival.

Slides:

Advertisements

Similar presentations

Advances and Emerging Therapy for Lung Cancer

Advertisements

Counts TLR3-PE Counts TLR8-PE Counts TLR9-PE C AB Supplemental Figure 1.

Supplemental Figure 1 A No. at risk T T T

A) 80 b) 53 c) 13 d) x 2 = : 10 = 3, x 3 = 309.

62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.

Giving Induction Radiation in Addition to Chemotherapy Is Not Associated with Improved Survival of NSCLC Patients with Operable Mediastinal Nodal Disease.

Lung resection surgical procedure to remove a portion of the lung or the whole lung.

Postoperative Radiotherapy for Patients with Stage II or III Nonsmall Cell Lung Cancer treated with Sublobar Resections: A SEER Registry Analysis Scott.

on behalf of the ACOSOG Z4032 Investigators

James Wade Sasa Espino Ashley Slaughter Thoracic Surgery

Kyung Hee University, Seoul, Korea GI Conference UGI Conference Presented by Byeong-Joo Noh Supervised by Youn-Wha Kim Kyung Hee University, Seoul, Korea.

Case 1. Diagnosis : Stomach, resection margin, proximal, FS-1, biopsy: No tumor Stomach, resection margin, distal, FS-2, biopsy: Adenocarcinoma Lymph.

R3 정상완. Introduction  EGC : Tumor invasion is limited to the mucosa or submucosa, regardless of lymph node involvement.  Accumulated histopathological.

Lung cancer Gene Kukuy, MD Cardiothoracic Surgery.

Kyung Hee University, Seoul, Korea GI Conference UGI Conference Presented by Byeong-Joo Noh Supervised by Youn-Wha Kim Kyung Hee University, Seoul, Korea.

Oesophago–Gastric Cancer

From: Population-Based Risk for Complications After Transthoracic Needle Lung Biopsy of a Pulmonary Nodule: An Analysis of Discharge Records Ann Intern.

The Relationship Between Volume or Surgeon Specialty and Outcome in the Surgical Treatment of Lung Cancer: A Systematic Review and Meta-Analysis Erik.

Prognosis of younger patients in non-small cell lung cancer

Volume 131, Issue 4, Pages (April 2007)

Elizabeth A. David, MD, David T

Volume 10, Issue 5, Pages (October 2008)

Outcomes of Sublobar Resection Versus Lobectomy for Stage I Non–Small Cell Lung Cancer: A 13-Year Analysis Amgad El-Sherif, MD, William E. Gooding, MS,

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

Gaetano Rocco, MD, FRCSEd

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer Sai-Hong Ignatius Ou, MD, PhD, Jason.

Surgical Treatment in Patient with Non–Small-Cell Lung Cancer with Fissure Involvement: Anatomical versus Nonanatomical Resection Giovanni Leuzzi, MD,

Surgical–pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non– small cell lung cancer: A heterogeneous disease Chung-Ping Hsu, MD,

Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program Giulia Veronesi, MD, Massimo Bellomi, MD,

Surgical quality of wedge resection affects overall survival in patients with early stage non–small cell lung cancer Gaurav S. Ajmani, MHS, Chi-Hsiung.

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,

Lobectomy with pulmonary artery resection: Morbidity, mortality, and long-term survival Marco Alifano, MD, Giacomo Cusumano, MD, Salvatore Strano, MD,

Resection of Mucinous Lung Adenocarcinoma Presenting with Intractable Bronchorrhea Motoshi Takao, MD, PhD, Takehiro Takagi, MD, Hitoshi Suzuki, MD, PhD,

Surgical resection of lung cancer originating in a tracheal bronchus

The Relationship Between Volume or Surgeon Specialty and Outcome in the Surgical Treatment of Lung Cancer: A Systematic Review and Meta-Analysis Erik.

Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study Morihito Okada, MD, PhD, Teruaki Koike, MD, PhD, Masahiko.

Surgical treatment of metachronous second primary lung cancer after complete resection of non–small cell lung cancer Masatsugu Hamaji, MD, Mark S. Allen,

Disease-specific survival

The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe Yukinori Sakao,

Surgical Treatment of Metachronous Second Primary Lung Cancer

Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy Morihito Okada, MD, Hiroyuki Yamagishi,

Table S1. Inverse correlation between FOXC2 and PP2A/C expression (tested by one-tailed Spearman's nonparametric correlation test, correlation coefficient.

Surgical treatment of non-small cell lung cancer 1 cm or less in diameter Daniel L Miller, MD, Charles M Rowland, MS, Claude Deschamps, MD, Mark S Allen,

흉부영상집답회 case review 강동경희대병원 이한나.

Andrea S. Wolf, MD, William G. Richards, PhD, Michael T

Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non–Small Cell Lung Cancer in the U.S. National Cancer Data Base

Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.

Lung Cancer and Prognosis in Taiwan: A Population-Based Cancer Registry Bing-Yen Wang, MD, Jing-Yang Huang, Ching-Yuan Cheng, MD, Ching-Hsiung Lin, MD,

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Onkar V. Khullar, MD, Yuan Liu, PhD, Theresa Gillespie, PhD, Kristin A

Prolonged survival in patients with resected non–small cell lung cancer and single-level N2 disease Steven M Keller, MD, Mark G Vangel, PhD, Henry Wagner,

Appropriateness of Surgical Approach in Black Patients with Lung Cancer—15 Years Later, Little Has Changed Emanuela Taioli, MD, PhD, Raja Flores, MD

Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD

The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients

The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: Implications for revision of the.

It’s All in the “Swerve of the Curve”

Long-Term Outcomes of 50 Cases of Limited-Resection Trial for Pulmonary Ground- Glass Opacity Nodules Masayuki Nakao, MD, Junji Yoshida, MD, PhD, Koichi.

Margin Distance Does Not Influence Recurrence and Survival After Wedge Resection for Lung Cancer Giulio Maurizi, MD, Antonio D’Andrilli, MD, Anna Maria.

The Prognostic Importance of Immunohistochemically Detected Node Metastases in Resected Esophageal Adenocarcinoma Tara A. Waterman, BA, Jeffrey A. Hagen,

Extent of lymphadenectomy is associated with oncological efficacy of sublobar resection for lung cancer ≤2 cm Brendon M. Stiles, MD, Jialin Mao, MD,

James D Luketich, Michael E Burt The Annals of Thoracic Surgery

Use of a Surgical Specimen-Collection Kit to Improve Mediastinal Lymph-Node Examination of Resectable Lung Cancer Raymond U. Osarogiagbon, MBBS, FACP,

Wedge Resection for Non-small Cell Lung Cancer in Patients with Pulmonary Insufficiency: Prospective Ten-Year Survival John P. Griffin, MD, Charles E.

Neal S Goldstein, MD The Annals of Thoracic Surgery

Norwegian Association for Cardiothoracic Surgery

Who should decide margin length in pulmonary excision of lung cancer?

Presentation transcript:

Supplemental Digital Content Figure 1A A Academic/Research Program Extent of Lung Resection No. of SubjectEventCensored Median Survival (95% CI)60 mo Survival Lobectomy (35%)1162 (65%)NA (99.6, NA)73.6% (71.4%, 75.6%) Segmental Resection13071 (55%)59 (45%)74.6 (58.9, 87.4)58.8% (49.7%, 66.9%) Wedge Resection (55%)325 (45%)71.2 (64, 77)57.4% (53.6%, 61.0%)

Supplemental Digital Content Figure 1B B Comprehensive Community Cancer Program Extent of Lung Resection No. of SubjectEventCensored Median Survival (95% CI)60 mo Survival Lobectomy (40%)1584 (60%)97.1 (92, 104)69.2% (67.3%, 71.0%) Segmental Resection12959 (46%)70 (54%)85.7 (61.3, NA)60.1% (50.7%, 68.3%) Wedge Resection (57%)428 (43%)66 (59.1, 70)52.6% (49.4%, 55.8%)

Supplemental Digital Content Figure 1C C Non-Comprehensive Community Cancer Program Extent of Lung Resection No. of SubjectEventCensored Median Survival (95% CI)60 mo Survival Lobectomy (40%)264 (60%)81.8 (73.8, NA)64.2% (59.1%, 68.8%) Segmental Resection2717 (63%)10 (37%)64.6 (46.3, NA)61.3% (40.0%, 77.0%) Wedge Resection18692 (49%)94 (51%)66.9 (53.8, 75.2)54.6% (46.3%, 62.1%)

Supplemental Digital Content Figure 2A A Tumor ≤ 1 cm Extent of Lung Resection No. of SubjectEventCensored Median Survival (95% CI)60 mo Survival Lobectomy (30%)503 (70%)NA (104.6, NA)76.7% (73.3%, 79.7%) Segmental Resection5121 (41%)30 (59%)94.9 (58.9, NA)64.1% (48.7%, 75.9%) Wedge Resection (47%)231 (53%)82.9 (75.4, 89.4)61.2% (56.3%, 65.8%)

Supplemental Digital Content Figure 2B B Tumor 1 – 2 cm Extent of Lung Resection No. of SubjectEventCensored Median Survival (95% CI)60 mo Survival Lobectomy (39%)2507 (61%)96.9 (93.2, 99.7)69.3% (67.8%, 70.7%) Segmental Resection (54%)109 (46%)73.5 (64.6, 79.9)58.7% (52.0%, 64.8%) Wedge Resection (58%)616 (42%)64.4 (59.9, 68.3)52.7% (50.0%, 55.3%)

Supplemental Digital Content Figure 3A A Regional Lymph Nodes Examined ≤ 7 Extent of Lung Resection No. of SubjectEventCensored Median Survival (95% CI)60 mo Survival Lobectomy (39%)1755 (61%)98.5 (92.2, 108.2)69.1% (67.3%, 70.8%) Segmental Resection (51%)121 (49%)74 (65.7, 89.3)60.3% (53.8%, 66.3%) Wedge Resection (56%)765 (44%)66.3 (62.2, 70.2)53.8% (51.3%, 56.2%)

Supplemental Digital Content Figure 3B B Regional Lymph Nodes Examined > 7 Extent of Lung Resection No. of SubjectEventCensored Median Survival (95% CI)60 mo Survival Lobectomy (36%)1255 (64%)100.6 (97.1, 110)72.3% (70.2%, 74.3%) Segmental Resection4022 (55%)18 (45%)69.5 (49.8, NA)54.8% (37.5%, 69.1%) Wedge Resection15270 (46%)82 (54%)79.6 (69.1, 97.7)64.4% (55.9%, 71.8%)

Supplemental Digital Content Figure 4A A Negative Surgical Margins Extent of Lung Resection No. of SubjectEventCensored Median Survival (95% CI)60 mo Survival Lobectomy (38%)2973 (62%)99.7 (96.9, 105.3)70.5% (69.1%, 71.8%) Segmental Resection (51%)136 (49%)74 (65.7, 87.4)59.6% (53.4%, 65.2%) Wedge Resection (55%)814 (45%)68.8 (64.8, 72.2)55.2% (52.8%, 57.6%)

Supplemental Digital Content Figure 4B B Positive Surgical Margins Extent of Lung Resection No. of SubjectEventCensored Median Survival (95% CI)60 mo Survival Lobectomy7437 (50%) 85.4 (62.7, 100.8)66.1% (53.8%, 75.9%) Segmental Resection63 (50%) 65.1 (18, NA)60.0% (12.6%, 88.2%) Wedge Resection9461 (65%)33 (35%)43.1 (31.5, 63.9)43.7% (33.3%, 53.6%)